Past Workshops
- Update On Marginal Zone Lymphoma (MZL)
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL)
Part II of Living with Mantle Cell Lymphoma (MCL) - Mantle Cell Lymphoma: Treatment Update
Part I of Living with Mantle Cell Lymphoma (MCL) - Follicular Lymphoma: Treatment Progress
- Diffuse Large B-Cell Lymphoma (DLBCL) Updates
- Marginal Zone Lymphoma (MZL): Treatment Updates
- What’s New in Diagnostic Technologies for People Living with Blood Cancers
Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer - Update from the 2021 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Part II of Equity. Every Patient. Every Day. Everywhere. - Transplantation as a Treatment Option for Blood Cancers
- Update on Marginal Zone Lymphoma (MZL)
- What’s New in Diagnostic Technologies for People Living with Blood Cancers
Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer - Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update on Diffuse Large B-Cell Lymphoma (DLBCL)
- Update on CAR T-Cell Therapies
- Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL)
Part II of Living with Mantle Cell Lymphoma - Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
- Treatment Update on Mantle Cell Lymphoma (MCL)
Part I of Living with Mantle Cell Lymphoma - Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Progress in the Treatment of Follicular Lymphoma
- Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
- Update on Diffuse Large B-Cell Lymphoma (DLBCL)
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in the Treatment of Hodgkin Lymphoma
- Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
Part II of Your Guide to the Latest Cancer Research and Treatment - Treatment Update on Mantle Cell Lymphoma (MCL)
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
- Taking Your Blood Cancer Treatment on Schedule
- The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
- Caregiving for Your Loved One with Mantle Cell Lymphoma
- Update on Diffuse Large B-Cell Lymphoma
- For Caregivers: Coping with a Loved One’s Waldenstrom’s Macroglobulinemia (WM)
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- The Emerging Role of Immunotherapy in the Treatment of Lymphoma